when was semaglutide fda approved Approves Oral for Weight Loss FDA Approval of Semaglutide for

Common side effects include nausea, diarrhea, and constipation usually subsiding over time

Poorly controlled diabetes increases the fetal risk for major birth defects, stillbirth and macrosomia related morbidity

Additionally, the introduction of Wegovy, an FDA-approved higher-dose version of Ozempic, intended to treat obesity, raises concerns about potential adverse effects

Popsicles made from diluted juice or electrolyte drinks can also provide fluid in a more tolerable format

In general, the study found that semaglutide use was associated with a 4x higher risk of NAION when used for treating type 2 diabetes and a 7x higher risk when used for treating obesity